Antibody-Drug Conjugates (ADCs) represent a rapidly advancing category of oncology therapeutics, spanning the targeted therapy for both hematologic malignancies and solid cancers. A crucial aspect of ...
CAR T cell therapy has revolutionized the treatment of many blood cancers, but has shown little success against solid tumors, which account for over 85% of all cancers. Columbia researchers have now ...
Cancer immunotherapy has greatly promoted the development of cancer treatment. However, due to the influence of tumour immune microenvironment, the response of solid cancers to immunotherapy is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results